Helicobacter, Inflammation, and Gastric Cancer

Current Pathobiology Reports

Volumn 1, Issue 1, 2013, Pages 9-18

  Sepulveda, Antonia R ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

DNA repair; Gastric cancer; H. pylori; Helicobacter; Inflammation; Mutation; Pathobiology; Stem cells

Indexed keywords

EID: 84883467387     PISSN: None     EISSN: 2167485X     Source Type: Journal    
DOI: 10.1007/s40139-013-0009-8     Document Type: Article

References (97)

1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
2. Warren JR, Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273–1275
3. Herrera V, Parsonnet J (2009) Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 15:971–976
4. International Agency for Research of Cancer (1994) Shistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 61:177–241
5. Palli D (2000) Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 35(Suppl 12):84–89
6. Gologan A, Graham DY, Sepulveda AR (2005) Molecular Markers in Helicobacter pylori-Associated Gastric Carcinogenesis. Clin Lab Med 25:197–222
7. Sepulveda AR, Aisner D (2009) Molecular basis of diseases of the gastrointestinal tract. In: Coleman WB, Tsongalis GJ (eds) Molecular pathology: the molecular basis of human disease. Academic Press, New York, pp 365–393
8. Yamaoka Y (2012) Pathogenesis of helicobacter pylori-related gastroduodenal diseases from molecular epidemiological studies. Gastroenterol Res Pract 2012:371503
9. Sepulveda A, Goyal A (2011) Helicobacter and Gastric Neoplasms. In: Tan D, Lauwers G (eds) Advances in Surgical Pathology: Gastric Cancer. Lippincott Williams and Wilkins, Philadelphia, pp 22–37
10. Makola D, Peura DA, Crowe SE (2007) Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 41:548–558
11. Bonifazi M, Malvezzi M, Bertuccio P et al (2011) Age-period-cohort analysis of oral cancer mortality in Europe: the end of an epidemic? Oral Oncol 47:400–407
12. Asaka M, Sugiyama T, Nobuta A et al (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6:294–299
13. Recavarren-Arce S, Leon-Barua R, Cok J et al (1991) Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol 26(Suppl 181):51–57
14. Sepulveda A, Peterson LE, Shelton J et al (2002) Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol 97:1365–1370
15. Leung WK, Kim JJ, Kim JG et al (2000) Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 156:537–543
16. Kang GH, Shim YH, Jung HY et al (2001) CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61:2847–2851
17. Sepulveda AR, Jones D, Ogino S et al (2009) CpG methylation analysis–current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. J Mol Diagn 11:266–278
18. Mikata R, Yokosuka O, Fukai K et al (2006) Analysis of genes upregulated by the demethylating agent 5-aza-2′-deoxycytidine in gastric cancer cell lines. Int J Cancer 119:1616–1622
19. Huang JQ, Sridhar S, Chen Y et al (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169–1179
20. Sepulveda AR, Wu L, Ota H et al (2000) Molecular identification of main cellular lineages as a tool for the classification of gastric cancer. Hum Pathol 31:566–574
21. Robinson K, Argent RH, Atherton JC (2007) The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21:237–259
22. McGee DJ, Mobley HL (2000) Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol 16:24–31
23. Beigier-Bompadre M, Moos V, Belogolova E et al (2011) Modulation of the CD4 + T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol alpha-glucoside content. J Infect Dis 204:1339–1348
24. Khamri W, Walker MM, Clark P et al (2010) Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4 + T lymphocytes. Infect Immun 78:845–853
25. • Kao JY, Zhang M, Miller MJ, et al. (2010) Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterol 138:1046–1054. This study showed that H. pylori directs Treg skewing through dendritic cell activation and inhibits Th17 immunity, allowing the chronic persistence of H. pylori infection which is critical for gastric carcinogenesis
26. Lamb A, Chen LF (2010) The many roads traveled by Helicobacter pylori to NFkappaB activation. Gut Microbes 1:109–113
27. Allison CC, Kufer TA, Kremmer E et al (2009) Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J Immunol 183:8099–8109
28. Chiba T, Marusawa H, Ushijima T (2012) Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143:550–563
29. Ziech D, Franco R, Pappa A et al (2011) Reactive oxygen species (ROS)–induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711:167–173
30. Sekikawa A, Fukui H, Fujii S et al (2008) REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 29:76–83
31. Kanda K, Komekado H, Sawabu T et al (2012) Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-alpha. EMBO Mol Med 4:396–411
32. Chen F (2012) JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 72:379–386
33. Lamb A, Chen LF (2012) Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer. J Cell Biochem. doi:10.1002/jcb.24389
34. Mills JC, Shivdasani RA (2011) Gastric epithelial stem cells. Gastroenterology 140:412–424
35. Barker N, Huch M, Kujala P et al (2010) Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6:25–36
36. Simon E, Petke D, Boger C et al (2012) The spatial distribution of LGR5 + cells correlates with gastric cancer progression. PLoS One 7:e35486
37. • Uehara T, Ma D, Yao Y, et al. (2012) H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci. [Epub ahead of print]. This study for the fist time showed that gastric epithelail stem cells are targets of mutagenesis in the H. pylori inflammatory mileau. The Lgr5-positive epithelial stem cell pool was expanded in H. pylori-associated gastritis in the antrum of patients with GC. In GC patients with active H. pylori infection, Lgr5-positive epithelial stem cells may be more susceptible to DNA damage than Lgr5-negative epithelial cells, suggesting that H. pylori infection may contribute to GC risk by affecting epithelial stem cells in the human stomach
38. Quante M, Marrache F, Goldenring JR et al (2010) TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. Gastroenterology 139:2018–2027. e2
39. May R, Sureban SM, Hoang N et al (2009) Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27:2571–2579
40. Qiao XT, Gumucio DL (2011) Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol 46:855–865
41. Correa P, Houghton J (2007) Carcinogenesis of Helicobacter pylori. Gastroenterology 133:659–672
42. Giannakis M, Chen SL, Karam SM et al (2008) Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA 105:4358–4363
43. Torres VJ, VanCompernolle SE, Sundrud MS et al (2007) Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol 179:5433–5440
44. Huang XW, Luo RH, Zhao Q et al (2011) Helicobacter pylori induces mitochondrial DNA mutation and reactive oxygen species level in AGS cells. Int J Med Sci 8:56–67
45. Yamaoka Y, Kodama T, Kashima K et al (1998) Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36:2258–2263
46. Handa O, Naito Y, Yoshikawa T (2007) CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol 73:1697–1702
47. Backert S, Naumann M (2010) What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 18:479–486
48. Suzuki M, Mimuro H, Kiga K et al (2009) Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5:23–34
49. • Sepulveda AR, Yao Y, Yan W, et al. (2010) CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology 138:1836–1844. This study highights the role of epigenetic regulation of the DNA repair protein MGMT in H. pylori infection underlying innefficent DNA repair in infected gastric mucosa which can contribute to the enhanced burden of tumorigenic mutational events in gastric epithelium during H. pylori-associated carinogenesis
50. Buti L, Spooner E, Van der Veen AG et al (2011) Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci USA 108:9238–9243
51. Tsang YH, Lamb A, Chen LF (2011) New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection. J Cell Biochem 112:381–386
52. •• Ohnishi N, Yuasa H, Tanaka S, et al. (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 105:1003–1008. This study for the first time demonstrated an oncogenic activity of H. pylori virulence factor CagA in vivo
53. El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402
54. Chattopadhyay R, Bhattacharyya A, Crowe SE (2010) Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during Helicobacter pylori infection. Cancer Res 70:2799–2808
55. Kim JJ, Tao H, Carloni E et al (2002) Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123:542–553
56. Kobayashi K, Okamoto T, Takayama S et al (2000) Genetic instability in intestinal metaplasia is a frequent event leading to well-differentiated early adenocarcinoma of the stomach. Eur J Cancer 36:1113–1119
57. Nakatsuru S, Yanagisawa A, Furukawa Y et al (1993) Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum Mol Genet 2:1463–1465
58. Shiao YH, Rugge M, Correa P et al (1994) p53 alteration in gastric precancerous lesions. Am J Pathol 144:511–517
59. Lee HS, Choi SI, Lee HK et al (2002) Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 15:632–640
60. Hunt JD, Mera R, Strimas A et al (2001) KRAS mutations are not predictive for progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev 10:79–80
61. Wang K, Kan J, Yuen ST et al (2011) Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 43:1219–1223
62. • Zang ZJ, Cutcutache I, Poon SL, et al. (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 44:570–574. This study illustrates the power of massively parallel sequencing technologies to identify key tumorigenic events in gastric cancers. Application to pre-neoplastic tissue analysis promises to unravel drivers of gastric carcinogenesis that may relate to H. pylori, inflammation or other specific underlying factors
63. Shimada T, Watanabe N, Hiraishi H et al (1999) Redox regulation of interleukin-8 expression in MKN28 cells. Dig Dis Sci 44:266–273
64. Verhulst ML, van Oijen AH, Roelofs HM et al (2000) Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci 45:629–632
65. Farinati F, Cardin R, Degan P et al (1998) Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 42:351–356
66. Yao Y, Tao H, Park DI et al (2006) Demonstration and characterization of mutations induced by Helicobacter pylori organisms in Gastric Epithelial Cells. Helicobacter 11:272–286
67. Park DI, Park SH, Kim SH et al (2005) Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 10:179–184
68. Umar A (2004) Lynch syndrome (HNPCC) and microsatellite instability. Dis Markers 20:179–180
69. Ling XL, Fang DC, Wang RQ et al (2004) Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions. World J Gastroenterol 10:800–803
70. Kashiwagi K, Watanabe M, Ezaki T et al (2000) Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 82:1814–1818
71. Abraham SC, Park SJ, Lee JH et al (2003) Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol 16:786–795
72. Lee JH, Abraham SC, Kim HS et al (2002) Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 161:611–618
73. Hayden JD, Martin IG, Cawkwell L et al (1998) The role of microsatellite instability in gastric carcinoma. Gut 42:300–303
74. Sepulveda AR, Santos AC, Yamaoka Y et al (1999) Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am J Gastroenterol 94:3034–3038
75. Ottini L, Palli D, Falchetti M et al (1997) Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 57:4523–4529
76. Yamamoto H, Sawai H, Perucho M (1997) Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 57:4420–4426
77. Shinmura K, Tani M, Isogaki J et al (1998) RER phenotype and its associated mutations in familial gastric cancer. Carcinogenesis 19:247–251
78. Myeroff LL, Parsons R, Kim SJ et al (1995) A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55:5545–5547
79. Chung YJ, Park SW, Song JM et al (1997) Evidence of genetic progression in human gastric carcinomas with microsatellite instability. Oncogene 15:1719–1726
80. Farinati F, Cardin R, Cassaro M et al (2008) Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 17:195–200
81. Park TJ, Han SU, Cho YK et al (2001) Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 92:2760–2768
82. Kim J, Leung W, Wu L et al (2000) Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells: a link with gastric carcinogenesis. Gastroenterology 118:A867
83. Matsumoto Y, Marusawa H, Kinoshita K et al (2010) Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. Gastroenterology 139:1984–1994
84. Toyota M, Ahuja N, Suzuki H et al (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438–5442
85. To KF, Leung WK, Lee TL et al (2002) Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102:623–628
86. Waki T, Tamura G, Sato M et al (2003) Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94:360–364
87. Kang GH, Lee S, Kim JS et al (2003) Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 83:635–641
88. Lee JH, Park SJ, Abraham SC et al (2004) Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23:4646–4654
89. Kang GH, Lee HJ, Hwang KS et al (2003) Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163:1551–1556
90. Qian X, Huang C, Cho CH et al (2008) E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett 263:107–113
91. Chan AO, Peng JZ, Lam SK et al (2006) Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 55:463–468
92. Belair C, Darfeuille F, Staedel C (2009) Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 15:806–812
93. • Zhang Z, Li Z, Gao C, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88:1358–1366. This study began to elucidate the potential contribution of microRNAs in H. pylori associated carcinogenesis, showing that miR-21 was significantly overexpressed in H. pylori-infected gastric mucosa, and implying that overexpression of miR-21 in gastric cancer may be due in part to H. pylori infection
94. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257–2261
95. Kong D, Piao YS, Yamashita S et al (2012) Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 31:3949–3960
96. Lam EK, Wang X, Shin VY et al (2011) A microRNA contribution to aberrant Ras activation in gastric cancer. Am J Transl Res 3:209–218
97. Xiao B, Liu Z, Li BS et al (2009) Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200:916–925